Skip to content

Effect of Supervised Remote Prehabilitation Before Periacetabular Osteotomy on Hip Function in Patients with Developmental Dysplasia of the Hip: A Prospective Single-Center Randomized Controlled Clinical Trial

Effect of Supervised Remote Prehabilitation Before Periacetabular Osteotomy on Hip Function in Patients with Developmental Dysplasia of the Hip: A Prospective Single-Center Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126272
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-16
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Dysplasia of the Hip

Interventions

Preoperative Rehabilitation Group:After the patient undergoes an outpatient examination and waits in line for a bed, they will receive 4-8 weeks of rehabilitation training guidance and preoperative co
Regular Group:After the patient undergoes an outpatient examination and waits in line for a bed, routine orthopedic education is provided, and the patient is given the same 'Preoperative Instructions

Sponsors

The Fourth Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-40 years; 2. Patients whose developmental hip dysplasia is confirmed by imaging results combined with the duration of symptoms; 3. Patients undergoing their first periacetabular osteotomy; 4. Patients who can tolerate the intensity of rehabilitation training; 5. Patients with good cognitive function, able to cooperate with and complete various rehabilitation treatments; 6. Subjects who voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who had lower limb joint surgery within 1 year before the operation; 2. Acute trauma or fracture of the lower limbs, systemic or neurological diseases; 3. Patients who have previously undergone PAO surgery on the contralateral side; 4. History of hip joint surgery on the same side; 5. Patients with other diseases or adverse health conditions that the investigator believes may affect their participation in this study, such as malignant diseases, serious illnesses, alcohol or drug addiction, or mental disorders; 6. Patients with obvious limited hip joint movement and other complications affecting the hip joint (such as hip impingement syndrome, femoral head necrosis, congenital clubfoot); 7. Patients currently participating in another clinical study; 8. Patients whom the investigator believes are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Hip function (iHOT-33 score);

Secondary

MeasureTime frame
Muscle strength (peak torque of major hip musculature);Joint range of motion (active and passive range of motion);Pain;Hip-related quality of life (HOS-ADL and HOS-SSS scores);Plantar pressure;Balance function;Anxiety level;

Countries

China

Contacts

Public ContactLi Xiao

the Fourth Medical Center of PLA General Hospital

352050114@qq.com+86 130 1120 0409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026